<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">BMC Complement Med Ther</span><span class="iso-abbrev" title="iso-abbrev">BMC Complement Med Ther</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">BMC Complementary Medicine and Therapies</span></div><span class="issn-epub" tagx="issn" title="issn-epub">2662-7671</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">BioMed Central</span><span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">London</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7836176">7836176</a></span><span class="publisher-id" title="publisher-id">3212</span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1186/s12906-021-03212-6">10.1186/s12906-021-03212-6</a></span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Research Article</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Yellow loosestrife (<i>Lysimachia vulgaris</i> var. <i>davurica</i>) ameliorates liver fibrosis in <i>db/db</i> mice with methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Son</span><span class="given-names" tagx="given-names" title="given-names">Yang-Ju</span></span><a href="#Aff1" /></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jung</span><span class="given-names" tagx="given-names" title="given-names">Da Seul</span></span><a href="#Aff1" /></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shin</span><span class="given-names" tagx="given-names" title="given-names">Ji Min</span></span><a href="#Aff1" /></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">Myungsuk</span></span><a href="#Aff1" /></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yoo</span><span class="given-names" tagx="given-names" title="given-names">Gyhye</span></span><a href="#Aff1" /></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">http://orcid.org/0000-0002-7805-0521</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nho</span><span class="given-names" tagx="given-names" title="given-names">Chu Won</span></span><span class="address" title="address"><span class="email" tagx="email" title="email">cwnho@kist.re.kr</span></span><a href="#Aff1" /></span><span class="citation_author_institution" id="Aff1">[], </span></div><span class="pub-date-epub" title="pub-date-epub">epub: <span>2021-1-1</span></span><span class="pub-date-pmc-release" title="pub-date-pmc-release">pmc-release: <span>2021-1-1</span></span><span class="pub-date-collection" title="pub-date-collection">collection: <span>2021</span></span><span class="volume" tagx="volume" title="volume">21</span><span class="elocation-id" tagx="elocation-id" title="elocation-id">44</span><span class="history" title="history"><span class="received" title="received">received: 2020-5-19</span><span class="accepted" title="accepted">accepted: 2021-1-10</span></span><div class="permissions"><span class="copyright" title="copyright">(C) , </span><span class="license" title="license"><span class="license-p" title="license-p"><b>Open Access</b>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</a>. The Creative Commons Public Domain Dedication waiver (<a href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</a>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</span></span></div> <div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <div class="background" title="sec"> <div class="title" tagx="title" title="title">
Background</div> <p id="Par1">Nonalcoholic steatohepatitis (NASH), a liver disease caused by a nonalcoholic fatty liver, is increasing in incidence worldwide. Owing to the complexity of its pathogenic mechanisms, there are no therapeutic agents for this disease yet. The ideal drug for NASH needs to concurrently decrease hepatic lipid accumulation and exert anti-inflammatory, antifibrotic, and antioxidative effects in the liver. Because of their multipurpose therapeutic effects, we considered that medicinal herbs are suitable for treating patients with NASH.</p> </div> <div class="methods" title="sec"> <div class="title" tagx="title" title="title">
Methods</div> <p id="Par2">We determined the efficacy of the alcoholic extract of <i>Lysimachia vulgaris</i> var. <i>davurica</i> (LV), an edible medicinal herb, for NASH treatment. For inducing NASH, C57BLKS/J lar-Lepr<sup>db</sup>/Lepr<sup>db</sup> (<i>db</i>/<i>db</i>) male mice were fed with a methionine-choline deficient (MCD) diet ad libitum. After 3â€‰weeks, the LV extract and a positive control (GFT505) were administered to mice by oral gavage for 3â€‰weeks with a continued MCD diet as needed.</p> </div> <div class="results" title="sec"> <div class="title" tagx="title" title="title">
Results</div> <p id="Par3">In mice with diet-induced NASH, the LV extract could relieve the disease symptoms; that is, the extract ameliorated hepatic lipid accumulation and also showed antioxidative and anti-inflammatory effects. The LV extract also activated nuclear factor E2-related factor 2 (Nrf2) expression, leading to the upregulation of antioxidants and detoxification signaling. Moreover, the extract presented remarkable efficacy in alleviating liver fibrosis compared with GFT505. This difference was caused by significant LV extract-mediated reduction in the mRNA expression of fibrotic genes like the alpha-smooth muscle actin and collagen type 3 alpha 1. Reduction of fibrotic genes may thus relate with the downregulation of transforming growth factor beta (TGFÎ²)/Smad signaling by LV extract administration.</p> </div> <div class="conclusions" title="sec"> <div class="title" tagx="title" title="title">
Conclusions</div> <p id="Par4">Lipid accumulation and inflammatory responses in the liver were alleviated by feeding LV extract to NASH-induced mice. Moreover, the LV extract strongly prevented liver fibrosis by blocking TGFÎ²/Smad signaling. Hence, LV showed sufficient potency for use as a therapeutic agent against NASH.</p> </div> <div class="supplementaryinformation" title="sec"> <div class="title" tagx="title" title="title">
Supplementary Information</div> <p>The online version contains supplementary material available at 10.1186/s12906-021-03212-6.</p> </div> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Keywords</div> <div class="kwd" title="kwd">
Yellow loosestrife</div> <div class="kwd" title="kwd"><i>Lysimachia vulgaris</i> var. <i>davurica</i></div> <div class="kwd" title="kwd">
Nonalcoholic fatty liver disease</div> <div class="kwd" title="kwd">
Nonalcoholic steatohepatitis</div> <div class="kwd" title="kwd">
Liver fibrosis</div> <div class="kwd" title="kwd">
TGFÎ²/Smad signaling</div> </div> <div class="funding-group" title="funding-group"> <div class="funding" title="funding">
Funding</div> <div class="award-group" title="award-group"> <div class="funding-source" title="funding-source"><span class="institution" title="institution">Korea Institute of Science and Technology</span></div><span class="award-id" tagx="award-id" title="award-id">2Z05630</span><span class="principal-award-recipient" title="principal-award-recipient"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nho</span><span class="given-names" tagx="given-names" title="given-names">Chu Won</span></span></span></div> </div> <div class="funding-group" title="funding-group"> <div class="funding" title="funding">
Funding</div> <div class="award-group" title="award-group"> <div class="funding-source" title="funding-source"><span class="institution" title="institution">National Research Foundation of Korea</span></div><span class="award-id" tagx="award-id" title="award-id">2008-00592</span><span class="principal-award-recipient" title="principal-award-recipient"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nho</span><span class="given-names" tagx="given-names" title="given-names">Chu Won</span></span></span></div> </div> <div class="custom-meta-group" title="custom-meta-group"> <meta name="issue-copyright-statement" value="Â© The Author(s) 2021" /> </div> </div> </div> <div class="body" title="body"> <div class="background" title="sec"> <div class="title" tagx="title" title="title">
Background</div> <p id="Par38">Nonalcoholic fatty liver disease (NAFLD) is increasingly becoming a worldwide health issue owing to the burgeoning cases of obesity in the global population. In developed countries, almost one third of adults have NAFLD, and its incidence among adolescents is also increasing [<a href="#CR1">1</a>]. NAFLD is an umbrella term that represents diseases ranging from fatty liver to nonalcoholic steatohepatitis (NASH), where the disorder can progress to cirrhosis and liver cancer [<a href="#CR2">2</a>]. NAFLD onset is caused by lipid droplet accumulation in the liver, which is mainly attributed to excess food consumption because the liver is a primary organ of de novo lipid synthesis. Hepatocytes produce triglycerides (TGs) and release lipids to the portal vein in the form of very-low-density lipoproteins (VLDLs) [<a href="#CR3">3</a>]. Although NASH development has been associated with inflammation caused by oxidative stress from excess lipids stored in the liver, the underlying mechanisms of fatty liver remain to be solved [<a href="#CR4">4</a>, <a href="#CR5">5</a>]. NASH can be distinguished from fatty liver based on the signs of inflammation, which can be accompanied with mild fibrosis. Continuous inflammatory reactions cause the loss of severely damaged hepatocytes, which are then superseded with fibrocytes [<a href="#CR6">6</a>]. Patients with cirrhosis, a form of NASH characterized by liver deterioration, experience irreversible liver dysfunction.</p> <p id="Par39">Development of efficacious therapies for NASH is still faced with unresolved challenges, owing to the multiple potential pathogenic pathways involved in the disease and their equivocal associations. Although the ultimate remedy for most patients is regulation of their body weight and diet, pharmacological therapies are still needed. The ideal drug for treating NASH should possess an assortment of characteristics, in that it should be able to reduce the hepatic fat content and also exert anti-inflammatory and antifibrotic effects [<a href="#CR7">7</a>]. Therefore, patients with NASH usually need to be prescribed several drugs for anti-obesity, anti-fatty liver, insulin receptor-sensitizing, anti-inflammatory, and antioxidative purposes [<a href="#CR8">8</a>]. However, taking a cocktail of drugs inevitably has latent side effects that limit its use. Therefore, herbal medicines, which mainly comprise crude extracts of medicinal plants, are used as conventional remedies globally. Although their overall chemical profiles are unknown and their mechanisms are unclear, the therapeutic effects and safety of medicinal plants in humans have been verified through their long-term use [<a href="#CR9">9</a>, <a href="#CR10">10</a>]. Through their cocktail effects from a mixture of innate herbal compounds, the multipurpose therapeutic effects of herbal medicine on human diseases have been well documented. Considering their complex potencies, we hypothesized that the efficacy of herbal medicines in NASH may be evaluated suitably.</p> <p id="Par40"><i>Lysimachia vulgaris</i> var. <i>davurica</i> (LV), also known as the yellow loosestrife, is a medicinal plant that is well known for treating ulcers, fever, inflammation, and diarrhea [<a href="#CR11">11</a>]. Recent findings have revealed that LV also has antifungal, antibacterial, antitumor, and antioxidative activities [<a href="#CR12">12</a>, <a href="#CR13">13</a>]. Moreover, LV is a non-toxic, edible plant that grows in Europe, North America, and Asian countries and is registered as a food ingredient in the Korean Food Standards Codex [<a href="#CR14">14</a>]. In a previous study, our research team found that LV is effective in a mouse model of diet-induced obesity, where it induced positive changes in lipid metabolism-related proteins and genes [<a href="#CR15">15</a>]. Moreover, we found some studies showing that <i>Lysimachia christinae</i> (which belongs to the same genus as LV) increased the detoxification mechanisms in liver [<a href="#CR16">16</a>, <a href="#CR17">17</a>]. Therefore, we hypothesized that LV could alleviate NASH by regulating lipid metabolism, and may mitigate oxidative stresses in the liver as well. Because of the lack of a proper therapeutic agent for NASH, we wanted to verify whether LV could be a novel therapeutic agent for treating NASH. Hence, in this study, we determined the efficacy of LV for the treatment of NASH, a disease with multiple symptoms and complex developmental mechanisms.</p> </div> <div class="methods" title="sec"> <div class="title" tagx="title" title="title">
Methods</div> <div class="preparationofanlvplantextract" title="sec"> <div class="title" tagx="title" title="title">
Preparation of an LV plant extract</div> <p id="Par41">An LV plant was collected from Pyeongchang, Gangwon-do, Korea in May of 2015. Plant samples were collected from a government-owned forest, permission was obtained in advance from the national forest center. The specimen was identified by Dr. Hyung Seok Kim, and a voucher specimen was deposited in the Korea Institute of Science and Technology (KIST) as specimen KIST-JSH-1505. The plant was dried with a cold-air dryer at 30â€‰Â°C for 7 days. In total, 5.88â€‰kg of the dried aerial parts was extracted three times with 99.5% ethanol using a reflux system for 4â€‰h, and the ethanol was evaporated in an evaporator at 40â€‰Â°C. The prepared LV extract was an extremely sticky liquid.</p> </div> <div class="animalmodeldesignandanimalexperiments" title="sec"> <div class="title" tagx="title" title="title">
Animal model design and animal experiments</div> <p id="Par42">Five-week-old C57BLKS/J lar-Lepr<sup>db</sup>/Lepr<sup>db</sup> (<i>db</i>/<i>db</i>) mice from Japan SLC, Inc. (Shizuoka, Japan) were obtained by the Central Lab. Animal, Inc. (Seoul, Korea). After 1â€‰week of acclimation, 22 mice were separated into four experimental groups according to their body weight. After the acclimation period, the MCS group was provided a diet supplemented with methionine and choline, whereas the other groups were fed a diet deficient in methionine and choline (MCD) (Research Diets, New Brunswick, NJ, USA) for 3 weeks. During the experimental period, the vehicle solution (0.5% carboxymethyl cellulose [CMC]) was provided to the MCS and MCD groups by oral gavage. The GFT group was administered elafibranor (GFT505) in 0.5% CMC solution at a dosage of 10â€‰mgÂ·kg<sup>âˆ’â€‰1</sup>Â·day<sup>âˆ’â€‰1</sup>. Similarly, the LYS group was administered LV extract at a dose of 100â€‰mgÂ·kg<sup>âˆ’â€‰1</sup>Â·day<sup>âˆ’â€‰1</sup>. After 3 weeks, the mice were administered a mixture of ketamine (80â€‰mg/kg) and xylazine (12â€‰mg/kg) via intraperitoneal injection and blood samples were collected from the heart. Mice were sacrificed by excessive blood collection during the anesthetized state and liver samples were collected. The animal experimental designs were approved by the Institutional Animal Care Use Committee of KIST (approval number KIST-2018-107; date of approval, December 28, 2018).</p> </div> <div class="biochemicalanalysis" title="sec"> <div class="title" tagx="title" title="title">
Biochemical analysis</div> <p id="Par43">The serum levels of alanine aminotransferase (ALT) (Cat. K752), aspartate aminotransferase (AST) (Cat. K753), TGs (Cat. K622), total cholesterol (TC) (Cat. K603), lactate dehydrogenase (LDH), high density lipoprotein cholesterol (HDL-c) (Cat. K613), and low density lipoprotein cholesterol (LDL-c) (Cat. K752) were analyzed using kits from BioVision (Minneapolis, MN, USA), following the manufacturerâ€™s recommended protocols. The alkaline phosphatase (ALP) levels in serum samples were analyzed using an assay kit from ANASPEC (Cat. AS-72146) (Fremont, CA, USA). The concentrations of TG, TC, malonaldehyde (MDA) (Cat. K719), and hydroxyproline (Cat. K226) in liver tissues were also measured using kits from BioVision (USA).</p> </div> <div class="histologicalanalysis" title="sec"> <div class="title" tagx="title" title="title">
Histological analysis</div> <p id="Par44">Liver tissues extracted from each mouse were fixed in 10% formalin solution and then embedded in paraffin to form paraffin blocks. These blocks were then cut into thin sections, some of which were stained with hematoxylin and eosin (H&amp;amp;E). The sections were also subjected to Sirius Red staining to observe collagen in the liver. To observe hepatic lipids, frozen optimum cutting temperature-embedded liver tissue specimens were prepared. The tissues were then sectioned with a cryostat and fixed in 4% formalin solution before staining with Oil Red O. Histological scoring of images after H&amp;amp;E staining was conducted as described by Kleiner et al. [<a href="#CR6">6</a>].</p> </div> <div class="real-timequantitativepolymerasechainreaction(qpcr)experiments" title="sec"> <div class="title" tagx="title" title="title">
Real-time quantitative polymerase chain reaction (qPCR) experiments</div> <p id="Par45">Total RNA was extracted from liver cells using the RNeasy Mini Kit (Qiagen, Hilden, Germany) and then reverse transcribed to complementary DNA (cDNA) using the PrimeScript 1st Strand cDNA Synthesis Kit (Takara Bio Inc., Kusatsu, Japan). To quantify the levels of specific mRNA, the cDNA was mixed with SYBR Green Master Mix (Hoffmann-La Roche Ltd., Schweiz, Switzerland), and the fluorescence after qPCR was analyzed with a Light Cycler 480 device (Hoffmann-La Roche, Ltd.) during amplification. The primer sequences used in this study were as follows: 5â€²- AGG TGT CCC AAA GAA GCT GTA-3â€² (F), 5â€²-ATG TCT GGA CCC ATT CCT TCT-3â€² (R), monocyte chemoattractant protein-1 (<i>MCP-1</i>); 5â€²-GCC TTG GTA GAG GTG ACT GAG-3â€² (F), 5â€²-GAC CGG AGC TGA AAA GTT GTA-3â€² (R), intercellular adhesion molecule 1 (<i>ICAM-1</i>); 5â€²-GTG GGG GAC GAA GCG CAG AG-3â€² (F), 5â€²-GGC CTT AGG GTT CAG CGG CG-3â€² (R), alpha-smooth muscle actin (<i>Î±-SMA</i>); 5â€²-GAC GCC ATC AAG GTC TAC TG-3â€² (F), 5â€²-ACG GGA ATC CAT CGG TCA-3â€² (R), collagen type-1 alpha 1 (<i>COL1A1</i>); 5â€²-GAG GAA TGG GTG GCT ATC CG-3â€² (F), 5â€²-TTG CGT CCA TCA AAG CCT CT-3â€² (R), collagen type-3 alpha 1 (<i>COL3A1</i>); and 5â€²-GCC CAA TAC GAC CAA ATC C-3â€² (F), 5â€²-AGC CAC ATC GCT CAG ACA C-3â€² (R), Glyceraldehyde 3-phosphate dehydrogenase (<i>GAPDH</i>).</p> </div> <div class="westernblotanalysis" title="sec"> <div class="title" tagx="title" title="title">
Western blot analysis</div> <p id="Par46">Liver samples were lysed with RIPA buffer containing a protease inhibitor cocktail (Sigmaâ€"Aldrich, St. Louis, MO, USA), after which the protein concentration of each lysate was measured. The protein concentration of each liver lysate was then equalized by dilution in an appropriate volume of RIPA buffer, after which the loading dye was added. Detection of chemiluminescence signals via western blot analysis was conducted using an LAS-3000 Bio Imaging System (Fuji Film Co., Tokyo, Japan), and the band density was measured using Image J software (NIH, Bethesda, MD, USA). As for primary antibodies, nuclear factor E2-related factor 2 (Nrf2) (Cat. sc-13,032), Heme oxygenase 1 (HO-1) (Cat. sc-390,991), matrix metalloproteinase 2 (MMP-2) (Cat. sc-13,595), and Î±-SMA (Cat. sc-53,142) were obtained from Santa Cruz Biotechnology (Dallas, TX, USA). The primary antibodies against transforming growth factor beta (TGFÎ²) (Cat. #3711), Smad2/3 (Cat. #5678), p-Smad2/3 (Cat. #8828S), and Smad4 (Cat. #38454) were purchased from Cell Signaling Technology (Danvers, MA, USA).</p> </div> <div class="high-performanceliquidchromatographyandtime-of-flighttandemmassspectrometry" title="sec"> <div class="title" tagx="title" title="title">
High-performance liquid chromatography and time-of-flight tandem mass spectrometry</div> <p id="Par47">The chemical profile of the ethanol extract of LV was analyzed by high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). The Phenomenex Kinetex C18 reversed phase column (2.1â€‰mmâ€‰Ã—â€‰150â€‰mm, 1.7â€‰Î¼m) that can construct ultra-HPLC (UPLC) analysis conditions in any liquid chromatography machine was equipped onto the HPLC apparatus (UltiMate 3000; Thermo Fisher Scientific, Waltham, MA, USA). Solvent A (0.1% formic acid in water) and solvent B (0.1% formic acid in acetonitrile) were prepared, and the mobile gradient was as follows: 0â€"10â€‰min, with an initial mobile gradient of A and B of 99:1; 15â€‰min, 90:10; 30â€‰min, 70:30; 40â€"41â€‰min, 30:70; 41â€"44â€‰min, 0:100; and 45â€"50â€‰min, 99:1. The flow rate was 0.2â€‰mL/min, the column temperature was 45â€‰Â°C, and detection was carried out at 254â€‰nm. After separation of the chemical compounds with HPLC, MS was performed using a Q-TOF 5600+ device (AB Sciex, Framingham, MA, USA) with electrospray ionization. The negative ionization mode was used for focusing on the flavonoids and phenolic compounds in the plant. The MS scan mode (50â€"1000â€‰m/z) was set to full scan and information-dependent acquisition. The MS operation conditions were as follows: 4.5â€‰kV capillary voltage; 400â€‰Â°C gas temperature; and 600â€‰L/h gas flow. For automatic MS/MS scanning of the abundant chemical compounds in the sample, the MS survey mode was used with auto switching collision-induced dissociation, and the collision energy range was âˆ’â€‰35â€‰Â±â€‰15â€‰eV. The tentative chemical compounds were determined by comparison against the analyzed MS/MS spectra and mass spectral libraries like the Human Metabolome Database and National Institute of Standards and Technology.</p> </div> <div class="statisticalanalysis" title="sec"> <div class="title" tagx="title" title="title">
Statistical analysis</div> <p id="Par48">The data generated in this study are presented as the meanâ€‰Â±â€‰standard deviation. For statistical analysis, one-way analysis of variance and Duncanâ€™s multiple range test were performed using the SPSS statistics program, version 25.0 (IBM, Inc., Armonk, NY, USA).</p> </div> </div> <div class="results" title="sec"> <div class="title" tagx="title" title="title">
Results</div> <div class="putativechemicalcompoundsoflv" title="sec"> <div class="title" tagx="title" title="title">
Putative chemical compounds of LV</div> <p id="Par49">Over 20 peaks were observed in the high-performance liquid chromatography (HPLC) chromatogram of an LV extract at 254â€‰nm, with the largest peak detected at 28.15â€‰min [see additionalÂ fileÂ <a href="#MOESM1">1</a>]. Ten putative chemical compounds were identified by comparing tandem mass spectrometry signals and HPLC retention times against those of mass spectral libraries. The profile of chemical compounds in the LV extract differed slightly from that reported previously, although chlorogenic acid, ferulic acid, and rutin were found as the major compounds in common between this study and the previous study [<a href="#CR18">18</a>].</p> </div> <div class="lvalleviatedliverdamageinnash" title="sec"> <div class="title" tagx="title" title="title">
LV alleviated liver damage in NASH</div> <p id="Par50">In contrast to the mice in the MCS group, mice in the MCD, GFT, and LYS groups all showed significantly reduced body weights (Fig.Â <a href="#Fig1">1</a>a). No significant difference in body weight was observed among the MCD diet-fed animals, with or without further treatment. However, mice in the positive-control group that was administered GFT505, showed significantly reduced liver weight/body weight ratios (Fig.Â <a href="#Fig1">1</a>b). Liver damage induced by NASH was examined by quantifying the ALT, AST, LDH, and ALP levels (Fig.Â <a href="#Fig1">1</a>c-f). All four enzyme were present at higher levels in the MCD group than in the MCS group, whereas AST, ALT, and ALP levels were significantly lower in the GFT and LYS groups (<i>p</i>Â <div class="â€‰0.05)._UNKNOWN" href="#Fig1">
1g-j). This absence of changes in the serum TG and cholesterol levels in the MCD diet-fed <i>db</i>/<i>db</i> mouse model agreed with the previous observations [<a href="#CR19">19</a>, <a href="#CR20">20</a>]. </div></p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 1</span></a></div>   <p>Body weights, liver weights, and biochemical indicators in the serum. Body weights were measured twice per week until day 21 (<b>a</b>). Liver weights were measured immediately after the mice were sacrificed; the liver weight/body weight ratio of each mouse is presented (<b>b</b>). The serum alanine aminotransferase (ALT) (<b>c</b>), aspartate aminotransferase (AST) (<b>d</b>), lactate dehydrogenase (LDH) (<b>e</b>), alkaline phosphatase (ALP), triglyceride (<b>g</b>), and total cholesterol (<b>h</b>), high density lipoprotein cholesterol (HDL-c) (<b>i</b>), low density lipoprotein cholesterol (LDL-c) (<b>j</b>) levels were measured. All data are presented as the meanâ€‰Â±â€‰SEM. One-way ANOVA and Duncanâ€™s multiple range test were conducted. Different superscripts within groups indicate significant differences at <i>p</i>â€‰<div class="â€‰0.05_UNKNOWN" /></p>   </div> <p /> </div> <div class="lvreducedlipidaccumulationandinflammation,andupregulatedantioxidativeproteinsintheliver" title="sec"> <div class="title" tagx="title" title="title">
LV reduced lipid accumulation and inflammation, and upregulated antioxidative proteins in the liver</div> <p id="Par51">FigureÂ <a href="#Fig2">2</a>a shows changes in the liver morphology, as determined by H&amp;amp;E staining. The unstained white round spots in the image, which are supposed to be lipid droplets, were larger in the liver tissues of MCD mice than the MCS mice. However, lipid droplets seemed to be highly diminished in liver tissues from mice in the GFT group. Histological scoring (Fig.Â <a href="#Fig2">2</a>b) was conducted using images of H&amp;amp;E staining, and the GFT group showed significantly reduced lipid accumulation in their liver tissues. The LYS group did not show significant alleviation of lipid accumulation; however, anomalous ballooning of hepatocytes was significantly reduced similar to that in the GFT group. Oil Red O staining was performed to clearly visualize lipid accumulation (Fig.Â <a href="#Fig3">3</a>a). Similar to H&amp;amp;E staining, Oil Red O staining demonstrated that the MCD group had larger lipid droplets over a larger area compared to the MCS group. Administering the LV extract seemed to have reduced the number of lipid droplets, and the GFT group seemed to highly reduce lipid accumulation, compared to the MCS group. The TG levels in liver tissues from the LYS and GFT groups decreased significantly as shown in Fig.Â <a href="#Fig3">3</a>b. However, no changes were observed in the liver TC levels, similar to the serum TC levels (Fig.Â <a href="#Fig3">3</a>c). Meanwhile, the mRNA levels of PPAR a and PPARr were determined as a key mediator of lipid homeostasis. (Fig.Â <a href="#Fig3">3</a>d). PPARÎ± level was significantly increased in the MCD group; however, this level was significantly lowered by GFT treatment (<i>p</i>Â <div class="â€‰0.05)._UNKNOWN">
pÂ <div class="â€‰0.05)._UNKNOWN" /></div></p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 2</span></a></div>   <p><i>Lysimachia vulgaris</i> var. <i>davurica</i>. (LV) ameliorated NASH pathogenesis. The liver tissues were stained with hematoxylin and eosin (<b>a</b>) and evaluated in terms of histopathological scores with NAS scoring (<b>b</b>). All data are presented as the meanâ€‰Â±â€‰SEM. One-way ANOVA and Duncanâ€™s multiple range test were conducted. Different superscripts within groups indicate significant differences at <i>p</i>â€‰<div class="â€‰0.05_UNKNOWN" /></p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 3</span></a></div>   <p>LV administration mitigated lipid accumulation in liver. Images of liver tissue sections stained with Oil Red O (<b>a</b>) and triglyceride (<b>b</b>), total cholesterol levels (<b>c</b>), and relative mRNA expressions of peroxisome proliferator-activated receptor-alpha (PPAR) Î± and Î³ (<b>d</b>) in liver tissues. All data are presented as the meanâ€‰Â±â€‰SEM. One-way ANOVA and Duncanâ€™s multiple range test were conducted. Different superscripts within groups indicate significant differences at <i>p</i>â€‰<div class="â€‰0.05_UNKNOWN" /></p>   </div> <p /> <p id="Par52">The MDA contents of liver tissues were analyzed for checking oxidative stress in the liver (Fig.Â <a href="#Fig4">4</a>a). The MDA content was significantly increased in the MCD group compared with that in the MCS group, whereas administration of GFT and LYS resulted in significantly decreased oxidative stress in the liver tissues (<i>p</i>Â <div class="â€‰0.05)._UNKNOWN">
pâ€‰<div class="â€‰0.05;_UNKNOWN" href="#Fig4">
4b-d). In contrast, treatment with GFT505 and the LV extract increased the protein-expression levels of Nrf2 and HO-1. Oxidative stress in cell systems can lead to inflammatory responses. Therefore, we anticipated that the LV extract could reduce inflammatory reactions by protecting cells against reactive oxygen species (ROS) induced due to NASH. To determine the extent of the inflammatory signaling in NASH, the gene-expression levels of <i>MCP-1</i> and <i>ICAM-1</i> were determined (Fig.Â <a href="#Fig4">4</a>e-f). Only the MCD group showed markedly higher expression levels of these two inflammation-related genes, whereas they were significantly downregulated by the LV extract and GFT505 (<i>p</i>â€‰<div class="â€‰0.05)._UNKNOWN" /></div></div></p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 4</span></a></div>   <p>LV extract elevated expression levels of anti-oxidative related proteins and inflammatory related mRNAs. The malonaldehyde (MDA) contents of liver tissues were analyzed (<b>a</b>). The bands were imaged after western blot analysis (<b>b</b>). The expression levels of the nuclear factor-E2 related factor 2 (Nrf2) (<b>c</b>) and heme oxygenase-1 (HO-1) (<b>d</b>) proteins were quantified by comparing their relative band densities to that of Î²-actin, using ImageJ software. The relative mRNA-expression levels of the monocyte chemoattractant protein-1 (<i>MCP-1</i>) (<b>e</b>) and intercellular adhesion molecule 1 (<i>ICAM-1</i>) genes (<b>f</b>) were quantified by performing quantitative polymerase chain reaction (qPCR) experiments. All data are presented as the meanâ€‰Â±â€‰SEM. One-way ANOVA and Duncanâ€™s multiple range test were conducted. Different superscripts within groups indicate significant differences at <i>p</i>â€‰<div class="â€‰0.05_UNKNOWN" /></p>   </div> <p /> </div> <div class="lvalleviatednash-relatedliverfibrosisanddownregulatedtgfÎ²/smad-dependentsignaling" title="sec"> <div class="title" tagx="title" title="title">
LV alleviated NASH-related liver fibrosis and downregulated TGFÎ²/Smad-dependent signaling</div> <p id="Par53">Sirius Red was used to stain the fibrotic regions in liver tissues, which appeared as yellow areas under the microscope (Fig.Â <a href="#Fig5">5</a>a), and these fibrotic regions in the liver were quantified by measuring the amounts of hydroxyproline in the tissues (Fig.Â <a href="#Fig5">5</a>b). Liver fibrosis decreased in the LYS group; however, interestingly, GFT505 did not ameliorate liver fibrosis. The GFT group presented high levels of hydroxyproline and in amounts similar to those in the MCD group. In contrast, the LYS group showed significantly reduced hydroxyproline levels. In addition, the mRNA expression levels of fibrogenesis-related genes decreased after treatment with LV extract (Fig.Â <a href="#Fig5">5</a>c). Moreover, we found that the levels of TGFÎ² and Smad signaling-related protein (TGF-Î²1, Smad2/3, p-Smad2/3, and Smad4), one of the key mechanisms regulating the expression of fibrotic genes, was significantly decreased in the LYS group compared with MCD (Fig.Â <a href="#Fig6">6</a>). </p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 5</span></a></div>   <p>LV extract alleviated liver fibrosis in NASH mice model. The mouse liver tissues were sectioned and stained with Sirius Red (<b>a</b>). The liver hydroxyproline content was measured with a commercial kit (<b>b</b>). The expression levels of genes related to liver fibrosis were determined by qPCR, including alpha smooth muscle actin (<i>Î±-SMA</i>), collagen, type-1, alpha 1 (<i>COL1A1</i>), and collagen, type-3, alpha 1 (<i>COL3A1</i>) (<b>c</b>). All data are presented as the meanâ€‰Â±â€‰SEM. One-way ANOVA and Duncanâ€™s multiple range test were conducted. Different superscripts within groups indicate significant differences at <i>p</i>â€‰<div class="â€‰0.05_UNKNOWN" /></p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 6</span></a></div>   <p>LV extract downregulated the TGFÎ² and Smad-dependent pathway in NASH mice. Protein-expression levels of TGFÎ² and transcriptional factors of fibrotic proteins were detected in liver tissues from mice with diet-induced nonalcoholic steatohepatitis (<b>a</b>). The relative protein-expression levels of TGFÎ², Smad2/3, p-Smad2/3, Smad4, MMP2, and Î±-SMA (<b>b</b>) were determined. All data are presented as the meanâ€‰Â±â€‰SEM. One-way ANOVA and Duncanâ€™s multiple range test were conducted. Different superscripts within groups indicate significant differences at <i>p</i>â€‰<div class="â€‰0.05_UNKNOWN" /></p>   </div> <p /> </div> </div> <div class="discussion" title="sec"> <div class="title" tagx="title" title="title">
Discussion</div> <p id="Par54">The MCD diet is a well-established experimental model for inducing severe NAFLD and NASH in animals. The liver is the major organ of lipogenesis in the body, being the site for both fatty acid uptake and de novo fatty acid synthesis. After hepatic lipogenesis, the liver secretes lipids into the portal vein, mostly in the form of VLDL, which consists mainly of apolipoprotein B and phosphatidyl choline (PC) [<a href="#CR21">21</a>]. Choline and methionine are precursors of PC; hence, the MCD diet causes a lack of PC in mice and consequently blocks the secretion of synthesized TGs from the liver to the blood [<a href="#CR19">19</a>]. Hence, mice fed the MCD diet accumulate excess lipids in the liver, which causes severe NAFLD. Moreover, the accumulated lipids undergo beta-oxidation; with ensuing excessive oxidative stress, this causes inflammation of hepatocytes and ultimately NASH [<a href="#CR22">22</a>]. However, there are drawbacks to mimicking human NAFLD in a mouse model with only the MCD diet. Most human patients with NASH and NAFLD have underlying obesity, whereas mice with MCD diet-induced NASH show a loss in body weight. Thus, genetically modified mice should be used to mimic the human disease. For example, the <i>db</i>/<i>db</i> mouse is a genetically modified animal that is used to study obesity and diabetes, and upon MCD diet administration, their pathogenic progression from obesity to NAFLD and NASH is similar to that of humans [<a href="#CR23">23</a>]. Therefore, <i>db</i>/<i>db</i> mice fed an MCD diet were used as the NASH model in this study. The severity of NASH in mice was evaluated with NAS scoring. The results revealed that ballooning significantly reduced in GFT and LYS groups (<i>p</i>â€‰<div class="â€‰0.05)._UNKNOWN" href="#CR24">
24]. Moreover, PPARs are nuclear receptors that play key roles in regulating lipid metabolism; these are also related to inflammation, cellular growth, and cell differentiation [<a href="#CR25">25</a>]. GFT505 caused downregulation of mRNA levels of <i>PPARÎ±</i> and <i>PPARÎ³</i> in liver tissues, and the LYS group also showed decreased <i>PPARÎ³</i> gene expressions. As a result, the GFT and LYS group showed significant mitigation of lipid accumulation in the liver compared to the MCD group.</div></p> <p id="Par55">Excessive accumulation of lipids in the liver causes inflammatory reactions, where oxidative stress may result from lipid oxidation. The Nrf2 and antioxidant-response element (ARE) pathway is one of the major detoxification pathways that enhances antioxidative responses [<a href="#CR26">26</a>]. Nrf2 belongs to the cap â€˜nâ€™ collar (CNC) family of basic-region leucine zipper (b-Zip) motifs, and Nrf2 and ARE regulate the phase II family of enzymes [<a href="#CR27">27</a>]. Among the CNC family members, Nrf2 is considered a key regulator that induces antioxidant-responsive genes by interacting with ARE [<a href="#CR28">28</a>]. <i>HO-1</i>, which is an antioxidant-responsive gene regulated by Nrf2, degrades heme to generate ferrous ion, CO, and biliverdin, all of which are related to the reduction of ROS [<a href="#CR29">29</a>]. In addition, few studies have reported the antioxidative activity of LV extract [<a href="#CR12">12</a>, <a href="#CR13">13</a>]. Consistent with these findings, we found that liver Nrf2 and HO-1 protein levels in LYS group were significantly increased, indicating that the extract regulates the Nrf2 activator within the cellular system. In addition, many lines of evidence indicate that Nrf2 and HO-1 can prevent lipid oxidation in vivo and that Nrf2 activation is sufficient to attenuate hepatic lipid accumulation in mice with alcohol-induced fatty liver [<a href="#CR30">30</a>, <a href="#CR31">31</a>]. Therefore, attenuation of lipid accumulation by the LV extract could be related to Nrf2 activation; however, further studies are needed to verify this possibility.</p> <p id="Par56">Liver fibrosis, which results from the replacement of hepatocytes with fibrotic cells during NASH pathogenesis, causes irreparable damage to the liver and loss of liver function. During liver cirrhosis, fibrous scars form along with the generation of myofibroblasts, the main sources of which are hepatic stellate cells (HSCs) [<a href="#CR32">32</a>]. In the normal liver, the major role of HSCs is in storing retinyl esters, a stored form of vitamin A [<a href="#CR33">33</a>]. However, HSCs are activated and transformed into myofibroblasts upon liver injury, and the expression levels of the related genes <i>Î±-SMA</i>, <i>COL1A1</i>, and <i>COL3A1</i> can increase [<a href="#CR34">34</a>]. In particular, the expression level of <i>Î±-SMA</i> is a reliable marker of activated HSCs, and is also strongly correlated with myofibroblast formation [<a href="#CR35">35</a>, <a href="#CR36">36</a>]. The mRNA-expression level of <i>Î±-SMA</i> was the highest in the GFT group, indicating that although GFT505 could attenuate lipid accumulation, oxidative stress, and inflammatory reactions in NASH, its recovery of damaged hepatocytes was not very effective. In contrast, the LYS group showed decreased levels of fibrosis-related genes. Meanwhile, as one of the key activator of HSCs in NASH pathogenesis, the inflammatory responses induced by Kupffer cells (KCs) are highly associated with NASH [<a href="#CR37">37</a>]. KCs are the resident macrophages in hepatic tissues, and produce pro-inflammatory cytokines and chemokines when NASH occurs [<a href="#CR38">38</a>, <a href="#CR39">39</a>]. Thus, KC activation is linked with the exacerbation of liver fibrosis in NASH pathogenesis. Although specific markers that can prove KC activation have not been determined in this study, we found that the contents of crucial chemokines (MCP-1 and ICAM-1) are decreased when LV and GFT are administered. Furthermore, we noted TGFÎ² as a mediator of inflammation and liver fibrosis mechanisms [<a href="#CR38">38</a>].</p> <p id="Par57">Substantial evidence indicates that TGFÎ² and Smad-dependent downstream signaling are key regulatory factors in liver fibrosis [<a href="#CR40">40</a>, <a href="#CR41">41</a>]. TGFÎ² receptor activation causes Smad2/3 phosphorylation and binding with Smad4, and this oligomer induces the transcription of fibrogenesis-related genes after it translocates to the nucleus [<a href="#CR42">42</a>]. TGFÎ² represents a predominant and central mediator of fibrosis in many organs in addition to the liver; therefore, it has been the target of therapeutic agents against fibrosis [<a href="#CR43">43</a>]. These protein-expression changes resulted in diminished Î±-SMA expression, a final product. In addition, the LV extract also significantly decreased (<i>p</i>â€‰<div class="â€‰0.05)_UNKNOWN" href="#CR44">
44]. Hence, it is surmised that the LV extract can ameliorate liver fibrosis by regulating an MMP-2-related pathway, although further studies are needed to verify this mechanism.</div></p> </div> <div class="conclusions" title="sec"> <div class="title" tagx="title" title="title">
Conclusions</div> <p id="Par58">In summary, we administered an LV extract to mice with MCD diet-induced NASH. The histopathological grades of NASH (based on the morphologies of liver sections) were ameliorated by LV supplementation, and lipid accumulation in the liver tissue also decreased. Moreover, treatment with the LV extract upregulated Nrf2, which may have improved the antioxidative and anti-inflammatory activities in the liver. Additionally, the LV extract strongly alleviated liver fibrosis by downregulating <i>Î±-SMA</i> and <i>COL3A1</i>. Mice fed the LV extract also showed decreased levels of proteins related to TGFÎ² and Smad signaling, which act upstream of fibrotic gene expression. Therefore, the potency of the LV extract in relieving liver fibrosis may result from blocking TGFÎ² and Smad signaling. In conclusion, the LV extract ameliorated NASH by alleviating lipid accumulation, oxidative stress, inflammation, and LV extract successfully relieved liver fibrosis. In particular, LV extract ameliorated liver fibrosis effectually in comparison with a dual PPARÎ±/Î´ agonist (GFT 505). These findings indicate many advantages for using the LV extract as a therapeutic agent against NASH.</p> </div> <div class="supplementary-material" title="supplementary-material"> <div class="title" tagx="title" title="title">
Supplementary Information</div> <div class="sec" title="sec"> <p> </p><div class="local-data" title="local-data"> <div class="media" title="media"><a href="12906_2021_3212_MOESM1_ESM.docx">LINK</a> <p><b>Additional file 1.</b> HPLC chromatogram at 254â€‰nm and mass spectra of the LV ethanol extract.</p>  </div> </div> <div class="local-data" title="local-data"> <div class="media" title="media"><a href="12906_2021_3212_MOESM2_ESM.docx">LINK</a> <p><b>Additional file 2.</b> The uncropped membrane images of western blotting analysis.</p>  </div> </div> <p /> </div> </div> </div> <div class="back" title="back"> <div class="glossary" title="glossary"> <div class="title" tagx="title" title="title">
Abbreviations</div> <div class="def-list" title="def-list"> <div class="def-item" title="def-item"> <div class="term" title="term">
NASH</div> <div class="def" title="def"> <p id="Par5">Nonalcoholic steatohepatitis</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
LV</div> <div class="def" title="def"> <p id="Par6"><i>Lysimachia vulgaris</i> var. davurica</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
db/db</div> <div class="def" title="def"> <p id="Par7">C57BLKS/J lar-Lepr<sup>db</sup>/Lepr<sup>db</sup></p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
MCD</div> <div class="def" title="def"> <p id="Par8">Methionine-choline deficient</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
NAFLD</div> <div class="def" title="def"> <p id="Par9">Nonalcoholic fatty liver disease</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
TGs</div> <div class="def" title="def"> <p id="Par10">Triglycerides</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
VLDLs</div> <div class="def" title="def"> <p id="Par11">Very-low-density lipoproteins</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
CMC</div> <div class="def" title="def"> <p id="Par12">Carboxymethyl cellulose</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
ALT</div> <div class="def" title="def"> <p id="Par13">Alanine aminotransferase</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
ALP</div> <div class="def" title="def"> <p id="Par14">Alkaline phosphatase</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
AST</div> <div class="def" title="def"> <p id="Par15">Aspartate aminotransferase</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
TC</div> <div class="def" title="def"> <p id="Par16">Total cholesterol</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
LDH</div> <div class="def" title="def"> <p id="Par17">Lactate dehydrogenase</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
H&amp;amp;E</div> <div class="def" title="def"> <p id="Par18">Hematoxylin and eosin</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
qPCR</div> <div class="def" title="def"> <p id="Par19">Real-time quantitative polymerase chain reaction</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
cDNA</div> <div class="def" title="def"> <p id="Par20">Complementary DNA</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
HPLC</div> <div class="def" title="def"> <p id="Par21">High-performance liquid chromatography</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
PPARÉ‘</div> <div class="def" title="def"> <p id="Par22">Peroxisome proliferator-activated receptor-alpha</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
Nrf2</div> <div class="def" title="def"> <p id="Par23">Nuclear factor E2-related factor 2</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
ROS</div> <div class="def" title="def"> <p id="Par24">Reactive oxygen species</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
MCP-1</div> <div class="def" title="def"> <p id="Par25">Monocyte chemoattractant protein-1</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
ICAM-1</div> <div class="def" title="def"> <p id="Par26">Intercellular adhesion molecule 1</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
TGFÎ²</div> <div class="def" title="def"> <p id="Par27">Transforming growth factor beta</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
PC</div> <div class="def" title="def"> <p id="Par28">Phosphatidyl choline</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
CNC</div> <div class="def" title="def"> <p id="Par29">Cap â€˜nâ€™ collar</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
b-Zip</div> <div class="def" title="def"> <p id="Par30">Basic-region leucine zipper</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
HSCs</div> <div class="def" title="def"> <p id="Par31">Hepatic stellate cells</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
Î±-SMA</div> <div class="def" title="def"> <p id="Par32">Alpha-smooth muscle actin</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
COL1A1</div> <div class="def" title="def"> <p id="Par33">Collagen type-1 alpha 1</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
COL3A1</div> <div class="def" title="def"> <p id="Par34">Collagen type-3 alpha 1</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
KC</div> <div class="def" title="def"> <p id="Par35">Kupffer cell</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
MMP-2</div> <div class="def" title="def"> <p id="Par36">Matrix metalloproteinase 2</p> </div> </div> <div class="def-item" title="def-item"> <div class="term" title="term">
LTBP</div> <div class="def" title="def"> <p id="Par37">Latency TGF-binding protein</p> </div> </div> </div> </div> <div class="fn-group" title="fn-group"> <div class="fn-type-" title=""> <p><b>Publisherâ€™s Note</b></p> <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p> </div> </div> <div class="ack" title="ack"> <div class="title" tagx="title" title="title">
Acknowledgements</div> <p>Not applicable.</p> </div> <div class="title" tagx="title" title="title">
Authorsâ€™ contributions</div> <p>YJS, GY, MK, and CWN designed the whole study. YJS carried out the HPLC-MS/MS analysis. YJS, DSJ, and JMS performed the animal experiments. All the authors have read the entire manuscript and approved its publication.</p> <div class="title" tagx="title" title="title">
Funding</div> <p>This work was supported by an intramural grant from the Korea Institute of Science and Technology, Gangneung Institute (grant number 2Z05630). This study was also supported by the Koreaâ€"Mongolia Cooperation Project from the National Research Foundation of Korea (NRF) (grant number 2008â€"00592). Both funders provided research cost of this study.</p> <div class="title" tagx="title" title="title">
Availability of data and materials</div> <p>Not applicable.</p> <div class="title" tagx="title" title="title">
Ethics approval and consent to participate</div> <p id="Par59">Not applicable.</p> <div class="title" tagx="title" title="title">
Consent for publication</div> <p id="Par60">Not applicable.</p> <div class="title" tagx="title" title="title">
Competing interests</div> <p id="Par61">The authors have no conflicts of interest to declare.</p> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="CR1" /><span class="label" tagx="label" title="label">1.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cohen</span><span class="given-names" tagx="given-names" title="given-names">JC</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Horton</span><span class="given-names" tagx="given-names" title="given-names">JD</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hobbs</span><span class="given-names" tagx="given-names" title="given-names">HH</span></span></span><span class="mixed-article-title" title="mixed-article-title">Human fatty liver disease: old questions and new insights</span><span class="source" tagx="source" title="source">Science</span><span class="year" tagx="year" title="year">2011</span><span class="volume" tagx="volume" title="volume">332</span><span class="fpage" tagx="fpage" title="fpage">1519</span><span class="lpage" tagx="lpage" title="lpage">1523</span><span class="pub-id"><a href="https://dx.doi.org/10.1126/science.1204265">10.1126/science.1204265</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21700865">21700865</a></span></span></li> <li tag="ref"><a name="CR2" /><span class="label" tagx="label" title="label">2.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matteoni</span><span class="given-names" tagx="given-names" title="given-names">CA</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Younossi</span><span class="given-names" tagx="given-names" title="given-names">ZM</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gramlich</span><span class="given-names" tagx="given-names" title="given-names">T</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Boparai</span><span class="given-names" tagx="given-names" title="given-names">N</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">YC</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">McCullough</span><span class="given-names" tagx="given-names" title="given-names">AJ</span></span></span><span class="mixed-article-title" title="mixed-article-title">Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity</span><span class="source" tagx="source" title="source">Gastoenterology</span><span class="year" tagx="year" title="year">1999</span><span class="volume" tagx="volume" title="volume">116</span><span class="fpage" tagx="fpage" title="fpage">1413</span><span class="lpage" tagx="lpage" title="lpage">1419</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/S0016-5085(99)70506-8">10.1016/S0016-5085(99)70506-8</a></span></span></li> <li tag="ref"><a name="CR3" /><span class="label" tagx="label" title="label">3.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Redgrave</span><span class="given-names" tagx="given-names" title="given-names">TG</span></span></span><span class="mixed-article-title" title="mixed-article-title">Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons</span><span class="source" tagx="source" title="source">J Clin Investig</span><span class="year" tagx="year" title="year">1970</span><span class="volume" tagx="volume" title="volume">49</span><span class="fpage" tagx="fpage" title="fpage">465</span><span class="lpage" tagx="lpage" title="lpage">471</span><span class="pub-id"><a href="https://dx.doi.org/10.1172/JCI106255">10.1172/JCI106255</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/5415674">5415674</a></span></span></li> <li tag="ref"><a name="CR4" /><span class="label" tagx="label" title="label">4.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Angulo</span><span class="given-names" tagx="given-names" title="given-names">P</span></span></span><span class="mixed-article-title" title="mixed-article-title">Nonalcoholic fatty liver disease</span><span class="source" tagx="source" title="source">N Engl J Med</span><span class="year" tagx="year" title="year">2002</span><span class="volume" tagx="volume" title="volume">346</span><span class="fpage" tagx="fpage" title="fpage">1221</span><span class="lpage" tagx="lpage" title="lpage">1231</span><span class="pub-id"><a href="https://dx.doi.org/10.1056/NEJMra011775">10.1056/NEJMra011775</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11961152">11961152</a></span></span></li> <li tag="ref"><a name="CR5" /><span class="label" tagx="label" title="label">5.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Farrell</span><span class="given-names" tagx="given-names" title="given-names">GC</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Larter</span><span class="given-names" tagx="given-names" title="given-names">CZ</span></span></span><span class="mixed-article-title" title="mixed-article-title">Nonalcoholic fatty liver disease: from steatosis to cirrhosis</span><span class="source" tagx="source" title="source">Hepatology</span><span class="year" tagx="year" title="year">2006</span><span class="volume" tagx="volume" title="volume">43</span><span class="fpage" tagx="fpage" title="fpage">S99</span><span class="lpage" tagx="lpage" title="lpage">112</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/hep.20973">10.1002/hep.20973</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16447287">16447287</a></span></span></li> <li tag="ref"><a name="CR6" /><span class="label" tagx="label" title="label">6.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kleiner</span><span class="given-names" tagx="given-names" title="given-names">DE</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Brunt</span><span class="given-names" tagx="given-names" title="given-names">EM</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">van Natta</span><span class="given-names" tagx="given-names" title="given-names">M</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Behling</span><span class="given-names" tagx="given-names" title="given-names">C</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Contos</span><span class="given-names" tagx="given-names" title="given-names">MJ</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cummings</span><span class="given-names" tagx="given-names" title="given-names">OW</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Design and validation of a histological scoring system for nonalcoholic fatty liver disease</span><span class="source" tagx="source" title="source">Hepatology</span><span class="year" tagx="year" title="year">2005</span><span class="volume" tagx="volume" title="volume">41</span><span class="fpage" tagx="fpage" title="fpage">1313</span><span class="lpage" tagx="lpage" title="lpage">1321</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/hep.20701">10.1002/hep.20701</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15915461">15915461</a></span></span></li> <li tag="ref"><a name="CR7" /><span class="label" tagx="label" title="label">7.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ratziu</span><span class="given-names" tagx="given-names" title="given-names">V</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Goodman</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sanyal</span><span class="given-names" tagx="given-names" title="given-names">A</span></span></span><span class="mixed-article-title" title="mixed-article-title">Current efforts and trends in the treatment of NASH</span><span class="source" tagx="source" title="source">J Hepatol</span><span class="year" tagx="year" title="year">2015</span><span class="volume" tagx="volume" title="volume">62</span><span class="fpage" tagx="fpage" title="fpage">S65</span><span class="lpage" tagx="lpage" title="lpage">S75</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.jhep.2015.02.041">10.1016/j.jhep.2015.02.041</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25920092">25920092</a></span></span></li> <li tag="ref"><a name="CR8" /><span class="label" tagx="label" title="label">8.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dunn</span><span class="given-names" tagx="given-names" title="given-names">W</span></span></span><span class="mixed-article-title" title="mixed-article-title">Therapies for non-alcoholic steatohepatitis</span><span class="source" tagx="source" title="source">Liver Res</span><span class="year" tagx="year" title="year">2017</span><span class="volume" tagx="volume" title="volume">1</span><span class="fpage" tagx="fpage" title="fpage">214</span><span class="lpage" tagx="lpage" title="lpage">220</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.livres.2017.12.006">10.1016/j.livres.2017.12.006</a></span></span></li> <li tag="ref"><a name="CR9" /><span class="label" tagx="label" title="label">9.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Balunas</span><span class="given-names" tagx="given-names" title="given-names">MJ</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kinghorn</span><span class="given-names" tagx="given-names" title="given-names">AD</span></span></span><span class="mixed-article-title" title="mixed-article-title">Drug discovery from medicinal plants</span><span class="source" tagx="source" title="source">Life Sci</span><span class="year" tagx="year" title="year">2005</span><span class="volume" tagx="volume" title="volume">78</span><span class="fpage" tagx="fpage" title="fpage">431</span><span class="lpage" tagx="lpage" title="lpage">441</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.lfs.2005.09.012">10.1016/j.lfs.2005.09.012</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16198377">16198377</a></span></span></li> <li tag="ref"><a name="CR10" /><span class="label" tagx="label" title="label">10.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kinghorn</span><span class="given-names" tagx="given-names" title="given-names">AD</span></span></span><span class="mixed-article-title" title="mixed-article-title">Pharmacognosy in the 21<sup>st</sup> century</span><span class="source" tagx="source" title="source">J Pharm Pharmacol</span><span class="year" tagx="year" title="year">2001</span><span class="volume" tagx="volume" title="volume">53</span><span class="fpage" tagx="fpage" title="fpage">135</span><span class="lpage" tagx="lpage" title="lpage">148</span><span class="pub-id"><a href="https://dx.doi.org/10.1211/0022357011775334">10.1211/0022357011775334</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11273009">11273009</a></span></span></li> <li tag="ref"><a name="CR11" /><span class="label" tagx="label" title="label">11.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Turker</span><span class="given-names" tagx="given-names" title="given-names">A</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guner</span><span class="given-names" tagx="given-names" title="given-names">B</span></span></span><span class="mixed-article-title" title="mixed-article-title">Efficient plant regeneration of yellow loosestrife (<i>Lysimachia vulgaris L</i>.), a medicinal plant</span><span class="source" tagx="source" title="source">Acta Biol Hung</span><span class="year" tagx="year" title="year">2013</span><span class="volume" tagx="volume" title="volume">64</span><span class="fpage" tagx="fpage" title="fpage">218</span><span class="lpage" tagx="lpage" title="lpage">230</span><span class="pub-id"><a href="https://dx.doi.org/10.1556/ABiol.64.2013.2.8">10.1556/ABiol.64.2013.2.8</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23739890">23739890</a></span></span></li> <li tag="ref"><a name="CR12" /><span class="label" tagx="label" title="label">12.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yildrim</span><span class="given-names" tagx="given-names" title="given-names">AB</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guner</span><span class="given-names" tagx="given-names" title="given-names">B</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Karakas</span><span class="given-names" tagx="given-names" title="given-names">FP</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Turker</span><span class="given-names" tagx="given-names" title="given-names">AU</span></span></span><span class="mixed-article-title" title="mixed-article-title">Evaluation of antibacterial, antitumor, antioxidant activities and phenolic constituents of field-grown and in vitro-grown <i>Lysimachia vulgaris L</i></span><span class="source" tagx="source" title="source">Afr J Tradit Complement Altern Med</span><span class="year" tagx="year" title="year">2017</span><span class="volume" tagx="volume" title="volume">14</span><span class="fpage" tagx="fpage" title="fpage">177</span><span class="lpage" tagx="lpage" title="lpage">187</span><span class="pub-id"><a href="https://dx.doi.org/10.21010/ajtcam.v14i2.19">10.21010/ajtcam.v14i2.19</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28573234">28573234</a></span></span></li> <li tag="ref"><a name="CR13" /><span class="label" tagx="label" title="label">13.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Podolak</span><span class="given-names" tagx="given-names" title="given-names">I</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Elas</span><span class="given-names" tagx="given-names" title="given-names">M</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cieszka</span><span class="given-names" tagx="given-names" title="given-names">K</span></span></span><span class="mixed-article-title" title="mixed-article-title">In vitro antifungal and cytotoxic activity of triterpene saponosides and quinoid pigments from <i>Lysimachia vulgaris L</i></span><span class="source" tagx="source" title="source">Phytother Res</span><span class="year" tagx="year" title="year">1998</span><span class="volume" tagx="volume" title="volume">12</span><span class="fpage" tagx="fpage" title="fpage">S70</span><span class="lpage" tagx="lpage" title="lpage">S73</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/(SICI)1099-1573(1998)12:1+&lt;S70::AID-PTR254&gt;3.0.CO;2-9">10.1002/(SICI)1099-1573(1998)12:1+<div class="s70::aid-ptr254_UNKNOWN">
3.0.CO;2-9</div></a></span></span></li> <li tag="ref"><a name="CR14" /><span class="label" tagx="label" title="label">14.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">SA</span></span></span><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shi</span><span class="given-names" tagx="given-names" title="given-names">J</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ho</span><span class="given-names" tagx="given-names" title="given-names">C-T</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shahidi</span><span class="given-names" tagx="given-names" title="given-names">F</span></span></span><span class="mixed-article-title" title="mixed-article-title">Traditional Functional Foods in Korea</span><span class="source" tagx="source" title="source">Asian Functional Foods</span><span class="year" tagx="year" title="year">1980</span><span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">USA</span><span class="publisher-name" tagx="publisher-name" title="publisher-name">CRC Press</span><span class="fpage" tagx="fpage" title="fpage">175</span></span></li> <li tag="ref"><a name="CR15" /><span class="label" tagx="label" title="label">15.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">SY</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">JY</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jhin</span><span class="given-names" tagx="given-names" title="given-names">C</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shin</span><span class="given-names" tagx="given-names" title="given-names">JM</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">M</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ahn</span><span class="given-names" tagx="given-names" title="given-names">HR</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Reduction of hepatic lipogenesis by loliolide and pinoresinol from <i>Lysimachia vulgaris</i> via degrading liver X receptors</span><span class="source" tagx="source" title="source">J Agric Food Chem</span><span class="year" tagx="year" title="year">2019</span><span class="volume" tagx="volume" title="volume">67</span><span class="fpage" tagx="fpage" title="fpage">12419</span><span class="lpage" tagx="lpage" title="lpage">12427</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/acs.jafc.9b01488">10.1021/acs.jafc.9b01488</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31610126">31610126</a></span></span></li> <li tag="ref"><a name="CR16" /><span class="label" tagx="label" title="label">16.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">JM</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cai</span><span class="given-names" tagx="given-names" title="given-names">H</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">JH</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">RX</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">YY</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">JY</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Detoxication mechanisms of Radix Tripterygium wilfordii via compatibility with Herba Lysimachia christinae in S180-bearing mice by involving Nrf2</span><span class="source" tagx="source" title="source">Biosci Rep</span><span class="year" tagx="year" title="year">2018</span><span class="volume" tagx="volume" title="volume">38</span><span class="fpage" tagx="fpage" title="fpage">BSR20180429</span><span class="pub-id"><a href="https://dx.doi.org/10.1042/BSR20180429">10.1042/BSR20180429</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29950302">29950302</a></span></span></li> <li tag="ref"><a name="CR17" /><span class="label" tagx="label" title="label">17.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">J</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cui</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">J</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">B</span></span></span><span class="mixed-article-title" title="mixed-article-title">Protective effect of <i>Lysimachia christinae</i> against acute alcohol-induced liver injury in mice</span><span class="source" tagx="source" title="source">Biosci Trends</span><span class="year" tagx="year" title="year">2012</span><span class="volume" tagx="volume" title="volume">6</span><span class="fpage" tagx="fpage" title="fpage">89</span><span class="lpage" tagx="lpage" title="lpage">97</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22621991">22621991</a></span></span></li> <li tag="ref"><a name="CR18" /><span class="label" tagx="label" title="label">18.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Toth</span><span class="given-names" tagx="given-names" title="given-names">A</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Toth</span><span class="given-names" tagx="given-names" title="given-names">G</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kery</span><span class="given-names" tagx="given-names" title="given-names">A</span></span></span><span class="mixed-article-title" title="mixed-article-title">Polyphenol composition and antioxidant capacity of three Lysimachia species</span><span class="source" tagx="source" title="source">Nat Prod Commun</span><span class="year" tagx="year" title="year">2014</span><span class="volume" tagx="volume" title="volume">9</span><span class="fpage" tagx="fpage" title="fpage">1473</span><span class="lpage" tagx="lpage" title="lpage">1478</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25522539">25522539</a></span></span></li> <li tag="ref"><a name="CR19" /><span class="label" tagx="label" title="label">19.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rinella</span><span class="given-names" tagx="given-names" title="given-names">ME</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Elias</span><span class="given-names" tagx="given-names" title="given-names">MS</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Smolak</span><span class="given-names" tagx="given-names" title="given-names">RR</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fu</span><span class="given-names" tagx="given-names" title="given-names">T</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Borensztajn</span><span class="given-names" tagx="given-names" title="given-names">J</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Green</span><span class="given-names" tagx="given-names" title="given-names">RM</span></span></span><span class="mixed-article-title" title="mixed-article-title">Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline=deficient diet</span><span class="source" tagx="source" title="source">J Lipid Res</span><span class="year" tagx="year" title="year">2008</span><span class="volume" tagx="volume" title="volume">49</span><span class="fpage" tagx="fpage" title="fpage">1068</span><span class="lpage" tagx="lpage" title="lpage">1076</span><span class="pub-id"><a href="https://dx.doi.org/10.1194/jlr.M800042-JLR200">10.1194/jlr.M800042-JLR200</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18227531">18227531</a></span></span></li> <li tag="ref"><a name="CR20" /><span class="label" tagx="label" title="label">20.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sahai</span><span class="given-names" tagx="given-names" title="given-names">A</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Malladi</span><span class="given-names" tagx="given-names" title="given-names">P</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pan</span><span class="given-names" tagx="given-names" title="given-names">X</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Paul</span><span class="given-names" tagx="given-names" title="given-names">R</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Melin-Aldana</span><span class="given-names" tagx="given-names" title="given-names">H</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Green</span><span class="given-names" tagx="given-names" title="given-names">RM</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin</span><span class="source" tagx="source" title="source">Am J Physiol- Gastr L</span><span class="year" tagx="year" title="year">2004</span><span class="volume" tagx="volume" title="volume">287</span><span class="fpage" tagx="fpage" title="fpage">G1035</span><span class="lpage" tagx="lpage" title="lpage">G1043</span><span class="pub-id"><a href="https://dx.doi.org/10.1152/ajpgi.00199.2004">10.1152/ajpgi.00199.2004</a></span></span></li> <li tag="ref"><a name="CR21" /><span class="label" tagx="label" title="label">21.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gruffat</span><span class="given-names" tagx="given-names" title="given-names">D</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Durand</span><span class="given-names" tagx="given-names" title="given-names">D</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Graulet</span><span class="given-names" tagx="given-names" title="given-names">B</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bauchart</span><span class="given-names" tagx="given-names" title="given-names">D</span></span></span><span class="mixed-article-title" title="mixed-article-title">Regulation of VLDL synthesis and secretion in the liver</span><span class="source" tagx="source" title="source">Reprod Nutr Dev</span><span class="year" tagx="year" title="year">1996</span><span class="volume" tagx="volume" title="volume">36</span><span class="fpage" tagx="fpage" title="fpage">375</span><span class="lpage" tagx="lpage" title="lpage">389</span><span class="pub-id"><a href="https://dx.doi.org/10.1051/rnd:19960404">10.1051/rnd:19960404</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8878355">8878355</a></span></span></li> <li tag="ref"><a name="CR22" /><span class="label" tagx="label" title="label">22.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Machado</span><span class="given-names" tagx="given-names" title="given-names">MV</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Michelotti</span><span class="given-names" tagx="given-names" title="given-names">GA</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xie</span><span class="given-names" tagx="given-names" title="given-names">G</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">de Almeida</span><span class="given-names" tagx="given-names" title="given-names">TP</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Boursier</span><span class="given-names" tagx="given-names" title="given-names">J</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bohnic</span><span class="given-names" tagx="given-names" title="given-names">B</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Correction: mouse models of diet-induced nonalcoholic Steatohepatitis reproduce the heterogeneity of the human disease</span><span class="source" tagx="source" title="source">PLoS One</span><span class="year" tagx="year" title="year">2015</span><span class="volume" tagx="volume" title="volume">10</span><span class="fpage" tagx="fpage" title="fpage">e0132315</span><span class="pub-id"><a href="https://dx.doi.org/10.1371/journal.pone.0132315">10.1371/journal.pone.0132315</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26121577">26121577</a></span></span></li> <li tag="ref"><a name="CR23" /><span class="label" tagx="label" title="label">23.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Larter</span><span class="given-names" tagx="given-names" title="given-names">CZ</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yeh</span><span class="given-names" tagx="given-names" title="given-names">MM</span></span></span><span class="mixed-article-title" title="mixed-article-title">Animal models of NASH: getting both pathology and metabolic context right</span><span class="source" tagx="source" title="source">J Gastroenterol Hepatol</span><span class="year" tagx="year" title="year">2008</span><span class="volume" tagx="volume" title="volume">23</span><span class="fpage" tagx="fpage" title="fpage">1635</span><span class="lpage" tagx="lpage" title="lpage">1648</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/j.1440-1746.2008.05543.x">10.1111/j.1440-1746.2008.05543.x</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18752564">18752564</a></span></span></li> <li tag="ref"><a name="CR24" /><span class="label" tagx="label" title="label">24.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cariou</span><span class="given-names" tagx="given-names" title="given-names">B</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zair</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Staels</span><span class="given-names" tagx="given-names" title="given-names">B</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bruckert</span><span class="given-names" tagx="given-names" title="given-names">E</span></span></span><span class="mixed-article-title" title="mixed-article-title">Effects of the new dual PPAR alpha/delta agonist GFT505 on lipid and glucose homeostasis in abdominally obese patients with combined dyslipidemia or impaired glucose metabolism</span><span class="source" tagx="source" title="source">Diabetes Care</span><span class="year" tagx="year" title="year">2011</span><span class="volume" tagx="volume" title="volume">34</span><span class="fpage" tagx="fpage" title="fpage">2008</span><span class="lpage" tagx="lpage" title="lpage">2014</span><span class="pub-id"><a href="https://dx.doi.org/10.2337/dc11-0093">10.2337/dc11-0093</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21816979">21816979</a></span></span></li> <li tag="ref"><a name="CR25" /><span class="label" tagx="label" title="label">25.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Poulsen</span><span class="given-names" tagx="given-names" title="given-names">L</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Siersbaek</span><span class="given-names" tagx="given-names" title="given-names">M</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mandrup</span><span class="given-names" tagx="given-names" title="given-names">S</span></span></span><span class="mixed-article-title" title="mixed-article-title">PPARs: fatty acid sensors controlling metabolism</span><span class="source" tagx="source" title="source">Semin Cell Dev Biol</span><span class="year" tagx="year" title="year">2012</span><span class="volume" tagx="volume" title="volume">23</span><span class="fpage" tagx="fpage" title="fpage">631</span><span class="lpage" tagx="lpage" title="lpage">639</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.semcdb.2012.01.003">10.1016/j.semcdb.2012.01.003</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22273692">22273692</a></span></span></li> <li tag="ref"><a name="CR26" /><span class="label" tagx="label" title="label">26.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nguyen</span><span class="given-names" tagx="given-names" title="given-names">T</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nioi</span><span class="given-names" tagx="given-names" title="given-names">P</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pickett</span><span class="given-names" tagx="given-names" title="given-names">CB</span></span></span><span class="mixed-article-title" title="mixed-article-title">The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress</span><span class="source" tagx="source" title="source">J Biol Chem</span><span class="year" tagx="year" title="year">2009</span><span class="volume" tagx="volume" title="volume">284</span><span class="fpage" tagx="fpage" title="fpage">13291</span><span class="lpage" tagx="lpage" title="lpage">13295</span><span class="pub-id"><a href="https://dx.doi.org/10.1074/jbc.R900010200">10.1074/jbc.R900010200</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19182219">19182219</a></span></span></li> <li tag="ref"><a name="CR27" /><span class="label" tagx="label" title="label">27.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Itoh</span><span class="given-names" tagx="given-names" title="given-names">K</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chiba</span><span class="given-names" tagx="given-names" title="given-names">T</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Takahashi</span><span class="given-names" tagx="given-names" title="given-names">S</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ishii</span><span class="given-names" tagx="given-names" title="given-names">T</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Igarashi</span><span class="given-names" tagx="given-names" title="given-names">K</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Katoh</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements</span><span class="source" tagx="source" title="source">Biochem Biophys Res Commun</span><span class="year" tagx="year" title="year">1997</span><span class="volume" tagx="volume" title="volume">236</span><span class="fpage" tagx="fpage" title="fpage">313</span><span class="lpage" tagx="lpage" title="lpage">322</span><span class="pub-id"><a href="https://dx.doi.org/10.1006/bbrc.1997.6943">10.1006/bbrc.1997.6943</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9240432">9240432</a></span></span></li> <li tag="ref"><a name="CR28" /><span class="label" tagx="label" title="label">28.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Motohashi</span><span class="given-names" tagx="given-names" title="given-names">H</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yamamoto</span><span class="given-names" tagx="given-names" title="given-names">M</span></span></span><span class="mixed-article-title" title="mixed-article-title">Nrf2-Keap1 defines a physiologically important stress response mechanism</span><span class="source" tagx="source" title="source">Trends Mol Med</span><span class="year" tagx="year" title="year">2004</span><span class="volume" tagx="volume" title="volume">10</span><span class="fpage" tagx="fpage" title="fpage">549</span><span class="lpage" tagx="lpage" title="lpage">557</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.molmed.2004.09.003">10.1016/j.molmed.2004.09.003</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15519281">15519281</a></span></span></li> <li tag="ref"><a name="CR29" /><span class="label" tagx="label" title="label">29.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Loboda</span><span class="given-names" tagx="given-names" title="given-names">A</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Damulewicz</span><span class="given-names" tagx="given-names" title="given-names">M</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pyza</span><span class="given-names" tagx="given-names" title="given-names">E</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Al</span><span class="given-names" tagx="given-names" title="given-names">J</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dulak</span><span class="given-names" tagx="given-names" title="given-names">J</span></span></span><span class="mixed-article-title" title="mixed-article-title">Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism</span><span class="source" tagx="source" title="source">Cell Mol Life Sci</span><span class="year" tagx="year" title="year">2016</span><span class="volume" tagx="volume" title="volume">73</span><span class="fpage" tagx="fpage" title="fpage">3221</span><span class="lpage" tagx="lpage" title="lpage">3247</span><span class="pub-id"><a href="https://dx.doi.org/10.1007/s00018-016-2223-0">10.1007/s00018-016-2223-0</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27100828">27100828</a></span></span></li> <li tag="ref"><a name="CR30" /><span class="label" tagx="label" title="label">30.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kang</span><span class="given-names" tagx="given-names" title="given-names">KW</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">SJ</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">SG</span></span></span><span class="mixed-article-title" title="mixed-article-title">Molecular mechanism of nrf2 activation by oxidative stress</span><span class="source" tagx="source" title="source">Antioxid Redox Signal</span><span class="year" tagx="year" title="year">2005</span><span class="volume" tagx="volume" title="volume">7</span><span class="fpage" tagx="fpage" title="fpage">1664</span><span class="lpage" tagx="lpage" title="lpage">1673</span><span class="pub-id"><a href="https://dx.doi.org/10.1089/ars.2005.7.1664">10.1089/ars.2005.7.1664</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16356128">16356128</a></span></span></li> <li tag="ref"><a name="CR31" /><span class="label" tagx="label" title="label">31.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">KC</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">J</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Klaassen</span><span class="given-names" tagx="given-names" title="given-names">CD</span></span></span><span class="mixed-article-title" title="mixed-article-title">Role of Nrf2 in preventing ethanol-induced oxidative stress and lipid accumulation</span><span class="source" tagx="source" title="source">Toxicol Appl Pharmacol</span><span class="year" tagx="year" title="year">2012</span><span class="volume" tagx="volume" title="volume">262</span><span class="fpage" tagx="fpage" title="fpage">321</span><span class="lpage" tagx="lpage" title="lpage">329</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.taap.2012.05.010">10.1016/j.taap.2012.05.010</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22627062">22627062</a></span></span></li> <li tag="ref"><a name="CR32" /><span class="label" tagx="label" title="label">32.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sun</span><span class="given-names" tagx="given-names" title="given-names">M</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kisseleva</span><span class="given-names" tagx="given-names" title="given-names">T</span></span></span><span class="mixed-article-title" title="mixed-article-title">Reversibility of liver fibrosis</span><span class="source" tagx="source" title="source">Clin Res Hepatol Gastroenterol</span><span class="year" tagx="year" title="year">2015</span><span class="volume" tagx="volume" title="volume">39</span><span class="fpage" tagx="fpage" title="fpage">S60</span><span class="lpage" tagx="lpage" title="lpage">S63</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.clinre.2015.06.015">10.1016/j.clinre.2015.06.015</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26206574">26206574</a></span></span></li> <li tag="ref"><a name="CR33" /><span class="label" tagx="label" title="label">33.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Friedman</span><span class="given-names" tagx="given-names" title="given-names">SL</span></span></span><span class="mixed-article-title" title="mixed-article-title">Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver</span><span class="source" tagx="source" title="source">Physiol Rev</span><span class="year" tagx="year" title="year">2008</span><span class="volume" tagx="volume" title="volume">88</span><span class="fpage" tagx="fpage" title="fpage">125</span><span class="lpage" tagx="lpage" title="lpage">172</span><span class="pub-id"><a href="https://dx.doi.org/10.1152/physrev.00013.2007">10.1152/physrev.00013.2007</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18195085">18195085</a></span></span></li> <li tag="ref"><a name="CR34" /><span class="label" tagx="label" title="label">34.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lua</span><span class="given-names" tagx="given-names" title="given-names">I</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zagory</span><span class="given-names" tagx="given-names" title="given-names">JA</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">KS</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">French</span><span class="given-names" tagx="given-names" title="given-names">SW</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">SÃ©vigny</span><span class="given-names" tagx="given-names" title="given-names">J</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Asahina</span><span class="given-names" tagx="given-names" title="given-names">K</span></span></span><span class="mixed-article-title" title="mixed-article-title">Characterization of hepatic stellate cells, portal fibroblasts, and mesothelial cells in normal and fibrotic livers</span><span class="source" tagx="source" title="source">J Hepatol</span><span class="year" tagx="year" title="year">2016</span><span class="volume" tagx="volume" title="volume">64</span><span class="fpage" tagx="fpage" title="fpage">1137</span><span class="lpage" tagx="lpage" title="lpage">1146</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.jhep.2016.01.010">10.1016/j.jhep.2016.01.010</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26806818">26806818</a></span></span></li> <li tag="ref"><a name="CR35" /><span class="label" tagx="label" title="label">35.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Carpino</span><span class="given-names" tagx="given-names" title="given-names">G</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Morini</span><span class="given-names" tagx="given-names" title="given-names">S</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Corradini</span><span class="given-names" tagx="given-names" title="given-names">SG</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Franchitto</span><span class="given-names" tagx="given-names" title="given-names">A</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Merli</span><span class="given-names" tagx="given-names" title="given-names">M</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Siciliano</span><span class="given-names" tagx="given-names" title="given-names">M</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation</span><span class="source" tagx="source" title="source">Dig Liver Dis</span><span class="year" tagx="year" title="year">2005</span><span class="volume" tagx="volume" title="volume">37</span><span class="fpage" tagx="fpage" title="fpage">349</span><span class="lpage" tagx="lpage" title="lpage">356</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.dld.2004.11.009">10.1016/j.dld.2004.11.009</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15843085">15843085</a></span></span></li> <li tag="ref"><a name="CR36" /><span class="label" tagx="label" title="label">36.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cherng</span><span class="given-names" tagx="given-names" title="given-names">S</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Young</span><span class="given-names" tagx="given-names" title="given-names">J</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ma</span><span class="given-names" tagx="given-names" title="given-names">H</span></span></span><span class="mixed-article-title" title="mixed-article-title">Alpha-smooth muscle actin (Î±-SMA)</span><span class="source" tagx="source" title="source">J Am Sci</span><span class="year" tagx="year" title="year">2008</span><span class="volume" tagx="volume" title="volume">4</span><span class="fpage" tagx="fpage" title="fpage">7</span><span class="lpage" tagx="lpage" title="lpage">9</span></span></li> <li tag="ref"><a name="CR37" /><span class="label" tagx="label" title="label">37.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tomita</span><span class="given-names" tagx="given-names" title="given-names">K</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tamiya</span><span class="given-names" tagx="given-names" title="given-names">G</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ando</span><span class="given-names" tagx="given-names" title="given-names">S</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ohsumi</span><span class="given-names" tagx="given-names" title="given-names">K</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chiyo</span><span class="given-names" tagx="given-names" title="given-names">T</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mizutani</span><span class="given-names" tagx="given-names" title="given-names">A</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Tumour necrosis factor a signaling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice</span><span class="source" tagx="source" title="source">Gut</span><span class="year" tagx="year" title="year">2006</span><span class="volume" tagx="volume" title="volume">55</span><span class="fpage" tagx="fpage" title="fpage">415</span><span class="lpage" tagx="lpage" title="lpage">424</span><span class="pub-id"><a href="https://dx.doi.org/10.1136/gut.2005.071118">10.1136/gut.2005.071118</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16174657">16174657</a></span></span></li> <li tag="ref"><a name="CR38" /><span class="label" tagx="label" title="label">38.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">C</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tao</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sun</span><span class="given-names" tagx="given-names" title="given-names">M</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">JZ</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">W</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jian</span><span class="given-names" tagx="given-names" title="given-names">P</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Kupffer cells are associated with apoptosis, inflammation and fibrotic effects in hepatic fibrosis in rats</span><span class="source" tagx="source" title="source">Lab Investig</span><span class="year" tagx="year" title="year">2010</span><span class="volume" tagx="volume" title="volume">90</span><span class="fpage" tagx="fpage" title="fpage">1805</span><span class="lpage" tagx="lpage" title="lpage">1806</span><span class="pub-id"><a href="https://dx.doi.org/10.1038/labinvest.2010.123">10.1038/labinvest.2010.123</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20921949">20921949</a></span></span></li> <li tag="ref"><a name="CR39" /><span class="label" tagx="label" title="label">39.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">J</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Leclercq</span><span class="given-names" tagx="given-names" title="given-names">I</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Brymora</span><span class="given-names" tagx="given-names" title="given-names">JM</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">N</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ramezani-Moghadam</span><span class="given-names" tagx="given-names" title="given-names">M</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">London</span><span class="given-names" tagx="given-names" title="given-names">RM</span></span></span><span class="mixed-article-title" title="mixed-article-title">Kupffer cells mediate leptin-induced liver fibrosis</span><span class="source" tagx="source" title="source">Gastroenterol</span><span class="year" tagx="year" title="year">2009</span><span class="volume" tagx="volume" title="volume">137</span><span class="fpage" tagx="fpage" title="fpage">713</span><span class="lpage" tagx="lpage" title="lpage">723</span><span class="pub-id"><a href="https://dx.doi.org/10.1053/j.gastro.2009.04.011">10.1053/j.gastro.2009.04.011</a></span></span></li> <li tag="ref"><a name="CR40" /><span class="label" tagx="label" title="label">40.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tang</span><span class="given-names" tagx="given-names" title="given-names">LX</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">He</span><span class="given-names" tagx="given-names" title="given-names">RH</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">G</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tan</span><span class="given-names" tagx="given-names" title="given-names">JJ</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Meng</span><span class="given-names" tagx="given-names" title="given-names">XM</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Asiatic acid inhibits liver fibrosis by blocking TGF-beta/Smad Signaling in vivo and in vitro</span><span class="source" tagx="source" title="source">PLoS One</span><span class="year" tagx="year" title="year">2012</span><span class="volume" tagx="volume" title="volume">7</span><span class="fpage" tagx="fpage" title="fpage">e31350</span><span class="pub-id"><a href="https://dx.doi.org/10.1371/journal.pone.0031350">10.1371/journal.pone.0031350</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22363627">22363627</a></span></span></li> <li tag="ref"><a name="CR41" /><span class="label" tagx="label" title="label">41.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Inagaki</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Okazaki</span><span class="given-names" tagx="given-names" title="given-names">I</span></span></span><span class="mixed-article-title" title="mixed-article-title">Emerging insights into transforming growth factor beta Smad signal in hepatic fibrogenesis</span><span class="source" tagx="source" title="source">Gut.</span><span class="year" tagx="year" title="year">2007</span><span class="volume" tagx="volume" title="volume">56</span><span class="fpage" tagx="fpage" title="fpage">284</span><span class="lpage" tagx="lpage" title="lpage">292</span><span class="pub-id"><a href="https://dx.doi.org/10.1136/gut.2005.088690">10.1136/gut.2005.088690</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17303605">17303605</a></span></span></li> <li tag="ref"><a name="CR42" /><span class="label" tagx="label" title="label">42.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Meng</span><span class="given-names" tagx="given-names" title="given-names">XM</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tang</span><span class="given-names" tagx="given-names" title="given-names">PM</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">J</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lan</span><span class="given-names" tagx="given-names" title="given-names">HY</span></span></span><span class="mixed-article-title" title="mixed-article-title">TGF- Î²/Smad signaling in renal fibrosis</span><span class="source" tagx="source" title="source">Front Physiol</span><span class="year" tagx="year" title="year">2015</span><span class="volume" tagx="volume" title="volume">6</span><span class="fpage" tagx="fpage" title="fpage">82</span><span class="pub-id"><a href="https://dx.doi.org/10.3389/fphys.2015.00082">10.3389/fphys.2015.00082</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25852569">25852569</a></span></span></li> <li tag="ref"><a name="CR43" /><span class="label" tagx="label" title="label">43.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Biernacka</span><span class="given-names" tagx="given-names" title="given-names">A</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dobaczewski</span><span class="given-names" tagx="given-names" title="given-names">M</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Frangogiannis</span><span class="given-names" tagx="given-names" title="given-names">NG</span></span></span><span class="mixed-article-title" title="mixed-article-title">TGF-Î² signaling in fibrosis</span><span class="source" tagx="source" title="source">Growth Factors</span><span class="year" tagx="year" title="year">2011</span><span class="volume" tagx="volume" title="volume">29</span><span class="fpage" tagx="fpage" title="fpage">196</span><span class="lpage" tagx="lpage" title="lpage">202</span><span class="pub-id"><a href="https://dx.doi.org/10.3109/08977194.2011.595714">10.3109/08977194.2011.595714</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21740331">21740331</a></span></span></li> <li tag="ref"><a name="CR44" /><span class="label" tagx="label" title="label">44.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">M</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">D</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Spinetti</span><span class="given-names" tagx="given-names" title="given-names">G</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">J</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jiang</span><span class="given-names" tagx="given-names" title="given-names">LQ</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pintus</span><span class="given-names" tagx="given-names" title="given-names">G</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Matrix metalloproteinase 2 activation of transforming growth factor-Î²1 (TGF-Î²1) and TGF-Î²1-type II receptor signaling within the aged arterial wall</span><span class="source" tagx="source" title="source">Arterioscl Throm Vas</span><span class="year" tagx="year" title="year">2006</span><span class="volume" tagx="volume" title="volume">26</span><span class="fpage" tagx="fpage" title="fpage">1503</span><span class="lpage" tagx="lpage" title="lpage">1509</span><span class="pub-id"><a href="https://dx.doi.org/10.1161/01.ATV.0000225777.58488.f2">10.1161/01.ATV.0000225777.58488.f2</a></span></span></li> </ul> </div> </div>  </body></html>